Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP509037.RAWNtm-MAdor471LsD_LGqQNLlhL9Ziv9-8ovuoB-XlnI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP509037.RAWNtm-MAdor471LsD_LGqQNLlhL9Ziv9-8ovuoB-XlnI130_assertion type Assertion NP509037.RAWNtm-MAdor471LsD_LGqQNLlhL9Ziv9-8ovuoB-XlnI130_head.
- NP509037.RAWNtm-MAdor471LsD_LGqQNLlhL9Ziv9-8ovuoB-XlnI130_assertion description "[To clarify their association and predictive value in treatment outcome of genotype 1 HCV-infected patients, we measured pretreatment serum IL-10, IL-12p40 and IL-18 levels using multiplex assays and determined IL28B gene polymorphisms (rs 8099917) in 52 cases with chronic hepatitis C.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP509037.RAWNtm-MAdor471LsD_LGqQNLlhL9Ziv9-8ovuoB-XlnI130_provenance.
- NP509037.RAWNtm-MAdor471LsD_LGqQNLlhL9Ziv9-8ovuoB-XlnI130_assertion evidence source_evidence_literature NP509037.RAWNtm-MAdor471LsD_LGqQNLlhL9Ziv9-8ovuoB-XlnI130_provenance.
- NP509037.RAWNtm-MAdor471LsD_LGqQNLlhL9Ziv9-8ovuoB-XlnI130_assertion SIO_000772 22024523 NP509037.RAWNtm-MAdor471LsD_LGqQNLlhL9Ziv9-8ovuoB-XlnI130_provenance.
- NP509037.RAWNtm-MAdor471LsD_LGqQNLlhL9Ziv9-8ovuoB-XlnI130_assertion wasDerivedFrom befree-20150227 NP509037.RAWNtm-MAdor471LsD_LGqQNLlhL9Ziv9-8ovuoB-XlnI130_provenance.
- NP509037.RAWNtm-MAdor471LsD_LGqQNLlhL9Ziv9-8ovuoB-XlnI130_assertion wasGeneratedBy ECO_0000203 NP509037.RAWNtm-MAdor471LsD_LGqQNLlhL9Ziv9-8ovuoB-XlnI130_provenance.